Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OxSODrol: An interim analysis of BTGC's Phase III trial

Bio-Technology General Corp. (BTGC), Iselin, N.J.
Product: OxSODrol recombinant superoxide

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE